Risk of death and the efficacy of eritoran tetrasodium (E5564): design considerations for clinical trials of anti-inflammatory agents in sepsis.

Source:http://linkedlifedata.com/resource/pubmed/id/20023474

Download in:

View as

General Info

PMID
20023474